Brazil vs Senegal: Immunization, Hib3
Brazil
91.0%
in 2024
Senegal
91.0%
in 2024
Brazil rank
90th
Senegal rank
90th
Immunization, Hib3 over time
- Brazil
- Senegal
How they compare
Brazil currently reports 91.0% against 91.0% in Senegal, a difference of 0.0%.
The two have swapped places 1 time across 20 shared years of data; in 2005 it was Brazil ahead.
Brazil ranks 90th and Senegal ranks 90th of 191 countries.
Across the 3 decades both report, Brazil averaged higher in 1 and Senegal in 2.
Head to head by decade
| Decade | Brazil | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.8% | 75.0% | 22.8% | Brazil |
| 2010s | 90.5% | 91.1% | 0.6% | Senegal |
| 2020s | 80.6% | 88.8% | 8.2% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Brazil or Senegal?
- Brazil, at 91.0% against 91.0% in Senegal as of 2024.
- What is the difference in immunization, hib3 between Brazil and Senegal?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Senegal?
- 20 years are reported by both, from 2005 to 2024.
- How do Brazil and Senegal rank globally for immunization, hib3?
- Brazil ranks 90th and Senegal ranks 90th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.